Persistence and adherence with antihypertensive drug therapy in a German sickness fund population von Höer, A, Gothe, H, Khan, Z M, Schiffhorst, G, Vincze, G, Häussler, B

Volltext

Identification and grouping of pain patients according to claims data von Freytag, A, Schiffhorst, G, Thoma, R, Strick, K, Gries, C, Becker, A, Treede, R-D, Müller-Schwefe, G, Casser, H-R, Luley, C, Höer, A, Ujeyl, M, Gothe, H, Kugler, J, Glaeske, G, Häussler, B

Volltext

Impact of the Early Benefit Assessment on A Pharmaceutical's Real Consumption in Germany von Kotowa, W, Häussler, B, Reindl, S, Höer, A

Volltext

Role of Antigen-Induced Cytokine Release in Atopic Pruritus von Lippert, U., Hoer, A., Möller, A., Ramboer, I., Cremer, B., Henz, B. M.

Volltext

Inositol 1,3,4,5,6-pentakisphosphate and inositol hexakisphosphate are inhibitors of the soluble inositol 1,3,4,5-tetrakisphosphate 3-phosphatase and the inositol 1,4,5-trisphospha... von Höer, A, Oberdisse, E

Volltext

Healthcare utilization of back pain patients: results of a claims data analysis von Müller-Schwefe, G., Freytag, A., Höer, A., Schiffhorst, G., Becker, A., Casser, H.-R., Glaeske, G., Thoma, R., Treede, R.-D.

Volltext

Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System von de Millas, C, Höer, A

Volltext

PCN291 - Regional Differences In Potential Savings For The Medical Treatment Of Advanced Prostate Cancer In The German Health Care System von de Millas, C, Höer, A

Volltext

PND73 Multiple Sclerosis in Germany: Outpatient Health Care Patterns von Höer, A, Schiffhorst, G, Fischaleck, J, Gehrmann, L, Ahrens, H, Carl, G, Sigel, K.O, Osowski, U, Bleβ, H.H

Volltext

Characterization of a phosphatidic acid phosphatase from rat brain cell membranes von Höer, A, Oberdisse, E

Volltext

Higher persistency with i.v. bisphosphonates in patients with bone metastasis von Mangiapane, S., Hoer, A., Gothe, H., Barghout, V., Haeussler, B.

Volltext

PNS144 HOW THE RESULTS OF THE AMNOG EARLY BENEFIT ASSESSMENT (EBA) IN GERMANY HAVE DEVELOPED OVER TIME von Reindl, S., Kotowa, W., Mathes, J., Höer, A.

Volltext

Thru-Reflect-Line: An Improved Technique for Calibrating the Dual Six-Port Automatic Network Analyzer von Engen, G.F., Hoer, C.A.

Volltext

Expression and regulation of phospholipase D in the human keratinocyte cell line HaCaT von Müller-Wieprecht, Verena, Riebeling, Christian, Alexander, Christian, Scholz, Frank-Rüdiger, Höer, Ariane, Wieder, Thomas, Orfanos, Constantin E, Geilen, Christoph C

Volltext

Properties of a soluble inositol 1,3,4,5-tetrakisphosphate 3-phosphatase from porcine brain von HOÊER, A, HOÊER, D, OBERDISSE, E

Volltext

PHP35 - AMNOG EARLY BENEFIT ASSESSMENT (EBA) AND MARKET PENETRATION OF NEW DRUGS FOR MELANOMA, MULTIPLE SCLEROSIS AND DIABETES MELLITUS IN GERMANY von Mathes, J., Höer, A.

Volltext

Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on h... von Höer, Ariane, Gothe, Holger, Schiffhorst, Guido, Sterzel, Astrid, Grass, Ulrich, Häussler, Bertram

Volltext

Low persistency with oral bisphosphonates in cancer patients von Hoer, A., Gothe, H., Barghout, V., Schiffhorst, G., Haeussler, B.

Volltext

A High-Power Automatic Network Analyzer for Measuring the RF Power Absorbed by Biological Samples in a TEM Cell von Juroshek, J.R., Hoer, C.A.

Volltext

PHP53 - Is The Proof of an Additional Benefit under amnog in Germany More Difficult for Certain Drugs than for Other Ones? von Kotowa, W, Reindl, S, Mathes, J, Doyno, T, Höer, A

Volltext